Aspartame pharmacokinetics - the effect of ageing

Puthrasingam, S, Heybroek, W M, Johnston, A, Maskrey, V, Swift, C G, Turner, P, Abrams, S M and Jackson, S H (1996) Aspartame pharmacokinetics - the effect of ageing. Age and Ageing, 25 (3). pp. 217-220. ISSN 0002-0729

Full text not available from this repository.


Aspartame is an intense sweetener which is increasingly used in the UK. It is registered at an acceptable daily intake (ADI) of 40 mg/kg, although there are no previous data relating to the metabolism of aspartame in older people. Twelve young and 12 elderly volunteers each received a single dose of approximately 40 mg/kg of aspartame. Baseline concentrations of phenylalanine (the main metabolite of aspartame) rose after ingestion with a significantly higher maximum concentration (Cmax) (81.3 vs. 63.3 micromol/1, p

Item Type: Article
Uncontrolled Keywords: adult,aged,aged, 80 and over,aging,aspartame,female,humans,male,metabolic clearance rate,phenylalanine,pilot projects,reference values
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 30 Apr 2015 12:32
Last Modified: 21 Oct 2022 00:50
DOI: 10.1093/ageing/25.3.217

Actions (login required)

View Item View Item